Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020
  2. Althoff, Keri N; Schlueter, David J; Anton-Culver, Hoda; Cherry, James; Denny, Joshua C; Thomsen, Isaac; Karlson, Elizabeth W; Havers, Fiona P; Cicek, Mine S; Thibodeau, Stephen N; Pinto,Ligia; Lowy, Douglas; Malin, Bradley A; Ohno-Machado, Lucila; Williams, Carolyn; Goldstein, David; Kouame, Aymone; Ramirez, Andrea; Roman, Adrienne; Sharpless, Norman E; Gebo, Kelly A; Schully, Sheri D
  3. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021, Jun 15;
  1. 2.   Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community
  2. Dimond, E. P.; Zon, R. T.; Weiner, B. J.; St Germain, D.; Denicoff, A. M.; Dempsey, K.; Carrigan, A. C.; Teal, R. W.; Good, M. J.; McCaskill-Stevens, W.; Grubbs, S. S.; Dimond, E. P.; Zon, R. T.; Weiner, B. J.; St Germain, D.; Denicoff, A. M.; Dempsey, K.; Carrigan, A. C.; Teal, R. W.; Good, M. J.; McCaskill-Stevens, W.; Grubbs, S. S.
  3. Journal of Oncology Practice. 2016, Jan; 12(1): 63-4, e23-35.
  1. 3.   Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets
  2. Adamson, C. S.; Freed, E. O.
  3. Molecular Interventions. 2009, Apr; 9(2): 70-4.
  1. 4.   Individualizing cancer care with interoperable information systems
  2. McCormick, K. A.
  3. Studies in Health Technology and Informatics. 2009 146: 383-390.
  1. 5.   Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study
  2. Mbulaiteye, S. M.; Atkinson, J. O.; Whitby, D.; Wohl, D. A.; Gallant, J. E.; Royal, S.; Goedert, J. J.; Rabkin, C. S.; Collaborators, A. C. C. S.
  3. Journal of Clinical Virology. 2006, Apr; 35(4): 442-449.
  1. 6.   Effects of electron-beam irradiation on whole genome amplification
  2. Bergen, A. W.; Qi, Y.; Haque, K. A.; Welch, R. A.; Garcia-Closas, M.; Chanock, S. J.; Vaught, J.; Castle, P. E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, APR; 14(4): 1016-1019.
  1. 7.   Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
  2. Iribarren, P.; Zhou, Y.; Hu, J. Y.; Le, Y. Y.; Wang, J. M.
  3. Immunologic Research. 2005 31(3): 165-176.
  1. 8.   Marine pharmacology in 2001-2: antitumour and cytotoxic compounds
  2. Mayer, A. M. S.; Gustafson, K. R.
  3. European Journal of Cancer. 2004, DEC; 40(18): 2676-2704.
  1. 9.   SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations
  2. Alley, M. C.; Hollingshead, M. G.; Pacula-Cox, C. M.; W, W. R.; Hartley, J. A.; Howard, P. W.; Gregson, S. J.; Thurston, D. E.; Sausville, E. A.
  3. Cancer Research. 2004, SEP 15; 64(18): 6700-6706.
  1. 10.   The hollow fibre model in cancer drug screening: the NCI experience
  2. Decker, S.; Hollingshead, M.; Bonomi, C. A.; Carter, J. P.; Sausville, E. A.
  3. European Journal of Cancer. 2004 40(6): 821-826.
  1. 11.   Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations
  2. Whitby, D.; Marshall, V. A.; Bagni, R. K.; Wang, C. D.; Gamache, C. J.; Guzman, J. R.; Kron, M.; Ebbesen, P.; Biggar, R. J.
  3. Journal of General Virology. 2004 85(Part 1): 155-163.
  1. 12.   MCP-1-MCP-3-eotaxin gene cluster influences HIV-1 transmission
  2. Modi, W. S.; Goedert, J. J.; Strathdee, S.; Buchbinder, S.; Detels, R.; Donfield, S.; O'Brien, S. J.; Winkler, C.
  3. Aids. 2003 17(16): 2357-2365.
  1. 13.   Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans
  2. Lautenberger, J. A.; Stephens, J. C.; O'Brien, S. J.; Smith, M. W.
  3. American Journal of Human Genetics. 2000 66(3): 969-78.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel